Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
Eton Pharmaceuticals announced positive results from a bioequivalence study of ET-600, its patented oral solution of desmopressin for central...
FDA Approves Expanded Label for Iluvien®
ANI Pharmaceuticals received FDA approval for an expanded label for ILUVIEN, adding chronic non-infectious uveitis affecting the posterior segment...
Avextra Cannabis Sleep Study 2025 Findings
Avextra’s IMPACT study reveals that its Cannabis Extract 10:10 significantly improved sleep quality and reduced pain in chronic pain...
Dyne-251 Shows Unprecedented Functional Improvement in DMD Trial
Dyne Therapeutics announced positive long-term clinical data from its Phase 1/2 DELIVER trial of DYNE-251 for Duchenne muscular dystrophy...
EnnoDC Presents Positive Phase I AMV Data at CROI 2025
EnnoDC’s Phase I ANRS VRI06 trial demonstrated that its Antibody Mediated Vaccine (AMV) technology induces a safe, durable, and...
BioAdaptives Zeranovia Weight Loss Dosage Trial Shows Promise
BioAdaptives, Inc. (OTC: BDPT) has completed dosage trials for its weight loss product, Zeranovia™, showing significant weight loss (5-7...
Kane Biotech Launches Innovative DispersinB® Acne Trial
Kane Biotech Inc. received approval from the University of Miami Health System’s Internal Review Board to begin a clinical...
Groundbreaking mRNA Biomarkers for Pancreatic Cancer Detection
Mainz Biomed has secured an exclusive license agreement with Liquid Biosciences for a portfolio of mRNA biomarkers aimed at...
Promising FAP Treatment: Phase 2 Trial of TPST-1495 Approved by FDA
Tempest Therapeutics has received FDA clearance for a Phase 2 clinical trial of TPST-1495, a dual prostaglandin E2 (PGE2)...
PDS Biotech gets FDA Clearance for Trial on Metastatic Colorectal Cancer Combo Therapy
PDS Biotechnology Corporation has received FDA clearance for its Investigational New Drug (IND) application to evaluate a combination therapy...